Kuya Silver Reports Strong Q2 Production Growth with 87% Increase in Mineralized Material Mined

Stock Information for Cipher Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Cipher Pharmaceuticals Inc.

Kuya Announces Amendment to Compensation Terms for Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption
Kuya Announces Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption
Kuya Silver Adds to Known Silver Mineralization at Bethania Project by Discovering New Silver Vein Zone and Expanding Surface Mineralization at Previously Identified Prospects
Kuya Silver Announces Issuance of Equity Awards
Kuya Silver Appoints Sheila Magallon as Chief Financial Officer
Kuya Silver Announces AGM Results and Appointment of Three New Directors
Kuya Silver Announces LOI for US$5 Million Royalty Partnership with Silver Crown Royalties Inc.
Kuya Silver Announces Joint Venture Agreement on Umm Hadid Silver-Gold Project, Saudi Arabia

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.